Delivery Order SPE2DB22D3004-SPE2DB26FQ67B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a contract value of $1,096.68. This firm fixed price delivery order is set to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order valued at $1,314.22 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity. The contract employs firm fixed price terms with no set-aside designation and was competitively awarded on September 26, 2025, with an ultimate completion date of September 29, 2025. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,068.80 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity. This competitively awarded, non-set-aside contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025, and employs firm fixed price terms. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.90 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00...
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a medical product used for treating certain digestive system conditions. The contract has a ceiling value of $2,060.50 and a completion date of October 27, 2023. The contract is a firm fixed-price delivery order, with no...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price of $2,482.57 and a completion date of June 30, 2025. The contract is not a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $460 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561903666 sucralfate 1 gm/10 ml susp 420ml. As the prime contractor, Amerisourcebergen Drug will deliver the pharmaceutical product to a facility in Conshohocken, Pennsylvania under a one day period of performance from August 22nd to August 23rd, 2023. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for critical...
- This federal contract award, valued at $1,067.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gm/10 ml suspension in 420 ml containers. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM/10 ML suspension in 420 ML containers. The $2,710.43 firm fixed price contract has an ultimate completion date of April 11, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, with...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ67BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, valued at $3,139.63. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The work is scheduled for completion by October 17, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare systems worldwide. The company's extensive federal contract history demonstrates consistent capability in fulfilling competitively awarded pharmaceutical delivery orders across multiple therapeutic domains, serving the Defense Health Agency and other government healthcare entities through flexible contract mechanisms designed to meet global medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 10/16/25 |